Paroxetine hydrochloride 40 MG Oral Tablet — RxCUI 1738511
RxNorm drug concept · Semantic clinical drug
RxCUI 1738511
Semantic clinical drug · SCD
● Current RxNorm concept 82 FDA products
258 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1738511
Official nameParoxetine hydrochloride 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asPARoxetine HCl 40 MG Oral Tablet
FDA products mapped82
Package NDCs mapped258
Reported Medicaid activity (SDUD)1,053,480 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Paroxetine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. Tablets and oral suspension treat depression, OCD, panic disorder, social anxiety, generalized anxiety, and PTSD in adults. Extended-release tablets trea...
- Take it once a day, usually in the morning, with or without food. The menopause capsule is taken at bedtime. Swallow extended-release tablets whole, and shake the suspension well....
- The most common are nausea, sleepiness, dry mouth, sweating, constipation or diarrhea, dizziness, trouble sleeping, and sexual side effects. Tell me or your doctor if they're bothe...
- Yes. Never combine it with MAOIs, thioridazine, or pimozide. Be careful with other serotonin-affecting drugs like triptans, tramadol, or St. John's Wort, and with aspirin, NSAIDs,...
🕸️ Concept Web — How Paroxetine hydrochloride 40 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Paroxetine hydrochloride 40 MG Oral Tablet
RxCUI 1738511 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Paroxetine
32937IN -
Paroxetine hydrochloride
235830PIN
-
Paroxetine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Paxil
114228BN
-
Paxil
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Paroxetine Oral Tablet
378925SCDF -
Paroxetine hydrochloride Oral Tablet
2646505SCDFP -
Paroxetine Oral Product
1164137SCDG -
Paroxetine Pill
1164138SCDG -
Paroxetine hydrochloride Oral Product
2662815SCDGP -
Paroxetine hydrochloride Pill
2663638SCDGP -
Paroxetine Oral Tablet [Paxil]
367670SBDF -
Paroxetine hydrochloride Oral Tablet [Paxil]
2655470SBDFP - +5 more in this family
-
Paroxetine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Paroxetine hydrochloride 40 MG
1738510SCDC -
Paroxetine hydrochloride 40 MG Oral Tablet [Paxil]
211700SBD -
Paroxetine hydrochloride 40 MG [Paxil]
1738512SBDC
-
Paroxetine hydrochloride 40 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Paroxetine hydrochloride 40 MG
SCDC · 1738510 -
Paroxetine Oral Tablet
SCDF · 378925 -
Paroxetine hydrochloride Oral Tablet
SCDFP · 2646505 -
Paroxetine Oral Product
SCDG · 1164137 -
Paroxetine Pill
SCDG · 1164138 -
Paroxetine hydrochloride Oral Product
SCDGP · 2662815 -
Paroxetine hydrochloride Pill
SCDGP · 2663638
Brand-Name Concepts
-
Paroxetine hydrochloride 40 MG Oral Tablet [Paxil]
SBD · 211700 -
Paroxetine hydrochloride 40 MG [Paxil]
SBDC · 1738512 -
Paroxetine Oral Tablet [Paxil]
SBDF · 367670 -
Paroxetine hydrochloride Oral Tablet [Paxil]
SBDFP · 2655470 -
Paxil Oral Product
SBDG · 1182921 -
Paxil Pill
SBDG · 1182922 -
Paxil
BN · 114228
📦 FDA Products & Package NDCs
82 products · 258 package NDCs
258 package NDCs map to RxCUI 1738511 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-7001-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-7001-10) | Paroxetine | Mylan Pharmaceuticals Inc. | 2008-03-24 |
| 00378-7001-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-7001-93) | Paroxetine | Mylan Pharmaceuticals Inc. | 2008-03-24 |
| 00378-7002-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-7002-10) | Paroxetine | Mylan Pharmaceuticals Inc. | 2008-03-24 |
| 00378-7002-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-7002-93) | Paroxetine | Mylan Pharmaceuticals Inc. | 2008-03-24 |
| 00378-7003-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-7003-10) | Paroxetine | Mylan Pharmaceuticals Inc. | 2008-03-24 |
| 00378-7003-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-7003-93) | Paroxetine | Mylan Pharmaceuticals Inc. | 2008-03-24 |
| 00378-7004-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-7004-10) | Paroxetine | Mylan Pharmaceuticals Inc. | 2008-03-24 |
| 00378-7004-93 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-7004-93) | Paroxetine | Mylan Pharmaceuticals Inc. | 2008-03-24 |
| 00615-7985-05 | 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-7985-05) | Paroxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2016-05-16 |
| 00615-7985-39 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-7985-39) | Paroxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2016-05-16 |
| 00615-8173-39 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8173-39) | Paroxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2018-03-07 |
| 00615-8174-39 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8174-39) | Paroxetine | NCS HealthCare of KY, LLC dba Vangard Labs | 2018-03-05 |
| 00904-5676-61 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-5676-61) / 1 TAB... | PAROXETINE | Major Pharmaceuticals | 2003-09-08 |
| 00904-5677-61 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-5677-61) / 1 TAB... | PAROXETINE | Major Pharmaceuticals | 2003-09-08 |
| 13107-0154-01 | 100 TABLET, FILM COATED in 1 BOTTLE (13107-154-01) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0154-05 | 500 TABLET, FILM COATED in 1 BOTTLE (13107-154-05) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0154-30 | 30 TABLET, FILM COATED in 1 BOTTLE (13107-154-30) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0154-90 | 90 TABLET, FILM COATED in 1 BOTTLE (13107-154-90) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0154-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (13107-154-99) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0155-01 | 100 TABLET, FILM COATED in 1 BOTTLE (13107-155-01) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0155-05 | 500 TABLET, FILM COATED in 1 BOTTLE (13107-155-05) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0155-30 | 30 TABLET, FILM COATED in 1 BOTTLE (13107-155-30) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0155-90 | 90 TABLET, FILM COATED in 1 BOTTLE (13107-155-90) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0155-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (13107-155-99) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0156-01 | 100 TABLET, FILM COATED in 1 BOTTLE (13107-156-01) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0156-05 | 500 TABLET, FILM COATED in 1 BOTTLE (13107-156-05) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0156-30 | 30 TABLET, FILM COATED in 1 BOTTLE (13107-156-30) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0156-90 | 90 TABLET, FILM COATED in 1 BOTTLE (13107-156-90) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0156-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (13107-156-99) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0157-01 | 100 TABLET, FILM COATED in 1 BOTTLE (13107-157-01) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0157-05 | 500 TABLET, FILM COATED in 1 BOTTLE (13107-157-05) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0157-30 | 30 TABLET, FILM COATED in 1 BOTTLE (13107-157-30) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0157-90 | 90 TABLET, FILM COATED in 1 BOTTLE (13107-157-90) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 13107-0157-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (13107-157-99) | Paroxetine | Aurolife Pharma LLC | 2009-12-03 |
| 43353-0544-15 | 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-544-15) | Paroxetine | Aphena Pharma Solutions - Tennessee, LLC | 2009-09-21 |
| 43353-0544-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-544-30) | Paroxetine | Aphena Pharma Solutions - Tennessee, LLC | 2019-02-01 |
| 43353-0544-45 | 45 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-544-45) | Paroxetine | Aphena Pharma Solutions - Tennessee, LLC | 2010-01-12 |
| 43353-0544-60 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-544-60) | Paroxetine | Aphena Pharma Solutions - Tennessee, LLC | 2019-03-18 |
| 43353-0554-15 | 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-554-15) | Paroxetine | Aphena Pharma Solutions - Tennessee, LLC | 2009-11-05 |
| 43353-0554-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-554-30) | Paroxetine | Aphena Pharma Solutions - Tennessee, LLC | 2019-02-01 |
| 43353-0554-45 | 45 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43353-554-45) | Paroxetine | Aphena Pharma Solutions - Tennessee, LLC | 2014-08-07 |
| 43547-0347-03 | 30 TABLET, FILM COATED in 1 BOTTLE (43547-347-03) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
| 43547-0347-09 | 90 TABLET, FILM COATED in 1 BOTTLE (43547-347-09) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
| 43547-0347-11 | 1000 TABLET, FILM COATED in 1 BOTTLE (43547-347-11) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
| 43547-0347-50 | 500 TABLET, FILM COATED in 1 BOTTLE (43547-347-50) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
| 43547-0348-03 | 30 TABLET, FILM COATED in 1 BOTTLE (43547-348-03) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
| 43547-0348-09 | 90 TABLET, FILM COATED in 1 BOTTLE (43547-348-09) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
| 43547-0348-11 | 1000 TABLET, FILM COATED in 1 BOTTLE (43547-348-11) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
| 43547-0348-50 | 500 TABLET, FILM COATED in 1 BOTTLE (43547-348-50) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
| 43547-0349-03 | 30 TABLET, FILM COATED in 1 BOTTLE (43547-349-03) | Paroxetine | Solco Healthcare US, LLC | 2022-03-29 |
Observed labelers:
Asclemed USA, Inc. (24) ·
Aurobindo Pharma Limited (20) ·
Aurolife Pharma LLC (20) ·
Oxford Pharmaceuticals, LLC (20) ·
Yiling Pharmaceutical, Inc. (20) ·
Zydus Lifesciences Limited (20)
· +18 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.